-
Global Chronic Obstructive Pulmonary Disease Treatment Devices Market to Witness Growth at a CAGR of ~6% by 2032 | DelveInsight
05 Aug 2025 17:00 GMT
… Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment … landscape, pipeline drug profiles, including … MediciNova, Edesa Biotech, Light Chain Biosciences, Boehringer Ingelheim, Genentech, Windtree Therapeutics, Biomarck Pharmaceuticals …
-
Challenges in Traditional Chinese Medicine Clinical Trials: How to Balance Personalized Treatment and Standardized Research?
11 Jul 2025 06:55 GMT
… medicine, TCM, clinical research, randomized controlled trials, RCT, TCM clinical trials, personalized treatment … a particular drug or treatment in humans … Chinese medicine combined with tiotropium bromide … adaptive multicenter clinical trial. Trials. 2022;23(1 …
-
Lupin receives FDA approval for generic Lotemax
11 Jul 2025 19:14 GMT
… corticosteroid indicated for the treatment of postoperative inflammation … from the Food and Drug Administration for loteprednol … Lupin, Sino Universal Pharmaceuticals ink deal for tiotropium DPI in China … [Read more: Lupin receives FDA OK for generic Banzel] …
-
Moderate Increase in Dementia Risk Linked to Tiotropium Use in Older COPD Patients: JAMA
03 Jul 2025 19:06 GMT
… of American Medical Association identified … drug';s respiratory benefits.
This study examined whether initiating tiotropium … treatment between 2004 and 2012. All participants were newly prescribed either tiotropium … target trial emulation framework, …
-
Lupin, Sino Universal Pharmaceuticals ink deal for tiotropium DPI in China
26 Jun 2025 01:56 GMT
…
[Read more: Lupin receives FDA OK for generic Banzel]
… solutions.”
[Read more: FDA gives Lupin tentative nod for … Lupin, a global pharmaceutical leader, on Tiotropium DPI,” said Wang … breakthroughs in respiratory disease treatment in China, allowing more …
-
Lupin and Sino Universal Partner to Supply Tiotropium DPI in China
18 Jun 2025 19:16 GMT
… with Lupin, a global pharmaceutical leader, on Tiotropium DPI,” said Wang Li … deep commitment to respiratory disease treatment and its innovation-driven approach … significant breakthroughs in respiratory disease treatment in China, allowing more patients …
-
Tiotropium Use in COPD Linked to Minimal Risk for Dementia
18 Jun 2025 13:04 GMT
… whether the initiation of tiotropium monotherapy affects the risk … with COPD should avoid tiotropium due to concerns about … measures, and other anticholinergic drugs. The assumption that the … The data for midlife medication dispensing and dementia biomarkers …
-
Paradigm Shift in the Treatment of Chronic Obstructive Pulmonary Disease Improves Patient Outcomes
16 Jun 2025 22:50 GMT
… trials have demonstrated its benefits, establishing these combinations as a key treatment … of individual medications, pharmaceutical manufacturers, dosages, or various drug combinations. However … -daily indacaterol versus tiotropium for patients with severe …
-
Lupin and Sino Universal Pharmaceuticals Sign License and Supply Agreement for Tiotropium DPI in China
16 Jun 2025 18:45 GMT
… with Lupin, a global pharmaceutical leader, on Tiotropium DPI," said Wang … deep commitment to respiratory disease treatment and its innovation-driven approach … significant breakthroughs in respiratory disease treatment in China, allowing more patients …
-
Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI
16 Jun 2025 16:09 GMT
… Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium … critical products for the treatment of respiratory diseases such … significant breakthroughs in respiratory disease treatment in China, allowing more …